Pharming Group N.V. Engages with Investors this June
Pharming Group N.V. is excited to announce its participation in several upcoming investor conferences this June, where management will showcase their commitment to innovation and healthcare. Pharming, known for its dedication to developing treatments for rare diseases, aims to connect with investors the world over.
Highlighting Key Conferences in June
Among the notable events, Pharming will have a significant presence at the Jefferies Global Healthcare Conference 2025, taking place in New York. On June 5, CEO Fabrice Chouraqui will engage attendees in a Fireside Chat Q&A session scheduled for 2:00 PM EDT. This interactive discussion will allow investors to gain insights into the company’s vision and strategic initiatives.
Additional Conference Engagements
Following the New York event, Pharming will participate in the Portzamparc (BNP Paribas) Mid & Small Caps Conference in Paris on June 18. This conference is another opportunity for Pharming to network with potential investors and partners, further emphasizing their continual growth and dedication to the biopharmaceutical sector.
Connect with Pharming’s Management
Investors interested in learning more about these conferences, or those wishing to schedule a one-on-one meeting with Pharming’s management team, can reach out to the Investor Relations team. They are accessible via email and are eager to assist in any inquiries regarding these crucial events.
About Pharming Group N.V.
Pharming Group N.V. is a leading biopharmaceutical company committed to transforming the lives of patients suffering from rare, debilitating diseases. With a focus on both small molecules and biologics, Pharming is dedicated to developing a portfolio of innovative therapies. Headquartered in Leiden, Pharming operates in more than 30 markets across North America, Europe, the Middle East, Africa, and Asia-Pacific, making a positive impact on patient care worldwide.
Innovation at the Core
With its state-of-the-art research and development capabilities, Pharming continually strives to enhance the quality of life for patients. Their focus is not only on commercialization but also on the discovery of new treatments that address unmet medical needs.
Frequently Asked Questions
What is Pharming Group N.V.?
Pharming Group N.V. is a biopharmaceutical company focused on developing treatments for rare diseases and conditions.
Which conferences will Pharming be attending in June?
Pharming will attend the Jefferies Global Healthcare Conference and the Portzamparc Mid & Small Caps Conference.
How can investors schedule a meeting with Pharming's management?
Investors can contact Pharming's Investor Relations team via email for meeting requests during the conferences.
Who is the CEO of Pharming?
The CEO of Pharming is Fabrice Chouraqui, who will be speaking at the upcoming conferences.
What markets does Pharming operate in?
Pharming operates in over 30 markets globally, including regions like North America, Europe, and Asia-Pacific.
